IGC Pharma Has Been Granted Canadian Patent Number 2961410 Titled "Cannabinoid Composition And Method For Treating Pain"
Portfolio Pulse from Happy Mohamed
IGC Pharma has been granted Canadian Patent Number 2961410 for a cannabinoid composition and method for treating pain. This could potentially open new revenue streams for the company.
July 11, 2023 | 5:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IGC Pharma's new patent could potentially open new revenue streams and increase the company's market value.
The granting of a new patent to IGC Pharma for a cannabinoid composition for pain treatment could potentially open new revenue streams for the company. This could increase the company's market value and make it more attractive to investors, potentially leading to a rise in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100